×
×
homepage logo
LOGIN
SUBSCRIBE

COVID-19

Pfizer profit soars in first quarter, revises 2022 forecast

COVID-19 vaccine and treatment sales helped Pfizer breeze past Wall Street's first-quarter expectations, as the drugmaker's profit grew 61%. The coronavirus vaccine Comirnaty brought in more than $13 billion in sales in the quarter, and the company is still trying to expand the market for the ...

Pfizer hopes to submit little-kid vaccine data by early June

Pfizer now hopes to tell U.S. regulators how well its COVID-19 vaccine works in the littlest kids by late May or early June. Pfizer is testing three extra-small doses of its vaccine in children under 5 after two shots didn't prove quite strong enough. Initial results had been expected last ...

COVID-19 cases grow in UMS ahead of weekend commencements

BANGOR, Maine (AP) — The number of COVID-19 cases is growing among students in the University of Maine System ahead of commencements this weekend. UMS officials reported that the number of cases on its campuses grew from 54 last week to 187 on Monday, a spike that led to a reinstatement of ...

Even as COVID cases rise, mask mandates stay shelved

NEW YORK (AP) — An increase in COVID-19 infections around the U.S. has sent more cities into new high-risk categories that are supposed to trigger indoor mask wearing, but much of the country is stopping short of bringing back restrictions amid deep pandemic fatigue. For weeks, much of ...

Harris negative for COVID-19 after taking antiviral pill

WASHINGTON (AP) — Vice President Kamala Harris tested negative on Monday for COVID-19, six days after she tested positive for the virus, and has been cleared to return to the White House on Tuesday. Harris press secretary Kirsten Allen said Harris, who was prescribed the antiviral treatment ...